Food frequency questionnaires showed that lower omega-6 to omega-3 ratios were best for improving asthma control.
Researchers at the University of Porto in Portugal believe that omega-3 alpha-linoleic acid (ALA) and omega-3s in general can encourage asthma control in asthmatic patients. Their research has been published in the British Journal of Nutrition.
The researchers assigned food frequency questionnaires to 174 asthmatics (average age of 40 years old) and used Food Processor Plus software to assess the nutritional content of subject diets.
Asthma control was defined by Asthma Control Questionnaire (ACQ) scores, levels of exhaled nitric oxide (nitric oxide is a sign of asthma via inflammation), and forced expiratory volume from breathing.
After adjusting for a variety of lifestyle factors, the researchers concluded that ability to control asthma was improved with lower omega-6 to omega-3 ratios in the diet; high omega-6 to omega-3 ratios was a predictor of high amounts of exhaled nitric oxide in subjects.
High intake of omega-3s, saturated fatty acid, and ALA independently were associated with lower levels of exhaled nitric oxide.
“The present results introduce a protective effect of ALA in asthma control, independent of marine n-3 fatty acids, and provide a rationale to dietary intervention studies in asthma,” concluded the researchers.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.